LN Sansom

444 total citations
11 papers, 371 citations indexed

About

LN Sansom is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Pharmacology. According to data from OpenAlex, LN Sansom has authored 11 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 6 papers in Pharmacology and 3 papers in Pharmacology. Recurrent topics in LN Sansom's work include Pharmacogenetics and Drug Metabolism (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Pharmaceutical studies and practices (4 papers). LN Sansom is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Pharmaceutical studies and practices (4 papers). LN Sansom collaborates with scholars based in Australia, United States and Belgium. LN Sansom's co-authors include Roger L. Nation, Felix Bochner, AA Somogyi, J. Robert Powell, Sidney Riegelman, S. Vožeh, J. F. Thiercelin, C. J. Doecke, John O. Miners and Michael E. McManus and has published in prestigious journals such as British Journal of Clinical Pharmacology, The Medical Journal of Australia and European Journal of Clinical Pharmacology.

In The Last Decade

LN Sansom

11 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
LN Sansom Australia 8 184 115 107 85 53 11 371
AA Somogyi Australia 6 192 1.0× 87 0.8× 79 0.7× 68 0.8× 54 1.0× 7 400
K Bachmann United States 12 209 1.1× 97 0.8× 146 1.4× 128 1.5× 31 0.6× 34 502
DD Breimer Netherlands 15 270 1.5× 147 1.3× 89 0.8× 123 1.4× 87 1.6× 21 689
Thomas Zysset Switzerland 16 203 1.1× 53 0.5× 89 0.8× 133 1.6× 37 0.7× 30 692
J. K. Boeijinga Netherlands 8 125 0.7× 61 0.5× 49 0.5× 57 0.7× 35 0.7× 13 348
DB Jack United Kingdom 15 152 0.8× 96 0.8× 153 1.4× 82 1.0× 77 1.5× 40 609
J. F. Thiercelin France 12 79 0.4× 115 1.0× 77 0.7× 63 0.7× 18 0.3× 21 399
A. J. CUMMINGS United Kingdom 13 166 0.9× 135 1.2× 83 0.8× 69 0.8× 43 0.8× 23 574
O. Borg� Sweden 11 126 0.7× 112 1.0× 141 1.3× 56 0.7× 59 1.1× 18 533
Gregory M. Kochak Switzerland 12 89 0.5× 105 0.9× 60 0.6× 77 0.9× 55 1.0× 34 483

Countries citing papers authored by LN Sansom

Since Specialization
Citations

This map shows the geographic impact of LN Sansom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LN Sansom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LN Sansom more than expected).

Fields of papers citing papers by LN Sansom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LN Sansom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LN Sansom. The network helps show where LN Sansom may publish in the future.

Co-authorship network of co-authors of LN Sansom

This figure shows the co-authorship network connecting the top 25 collaborators of LN Sansom. A scholar is included among the top collaborators of LN Sansom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with LN Sansom. LN Sansom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Nation, Roger L., et al.. (1993). The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis.. British Journal of Clinical Pharmacology. 36(3). 185–193. 29 indexed citations
2.
Doecke, C. J., et al.. (1991). Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.. British Journal of Clinical Pharmacology. 31(2). 125–130. 96 indexed citations
4.
Nation, Roger L., et al.. (1989). Lack of effect of co‐trimoxazole on the pharmacokinetics of orally administered theophylline. Biopharmaceutics & Drug Disposition. 10(6). 573–580. 2 indexed citations
5.
Milne, Robert, Kingsley Coulthard, Roger L. Nation, et al.. (1988). Lack of effect of erythromycin on the pharmacokinetics of single oral doses of phenytoin.. British Journal of Clinical Pharmacology. 26(3). 330–333. 10 indexed citations
6.
Nation, Roger L., et al.. (1988). Stereoselective drug disposition: potential for misinterpretation of drug disposition data.. British Journal of Clinical Pharmacology. 26(6). 771–780. 49 indexed citations
7.
Schapel, Graham J., Roy G. Beran, C. J. Doecke, et al.. (1980). Pharmacokinetics of sodium valproate in epileptic patients: Prediction of maintenance dosage by single-dose study. European Journal of Clinical Pharmacology. 17(1). 71–77. 14 indexed citations
8.
Sansom, LN, Roy G. Beran, & Graham J. Schapel. (1980). INTERACTION BETWEEN PHENYTOIN AND VALPROATE. The Medical Journal of Australia. 2(4). 212–212. 3 indexed citations
9.
Sansom, LN, et al.. (1979). Interaction between phenytoin and sodium valproate. Pathology. 11(2). 326–326. 1 indexed citations
10.
Powell, J. Robert, J. F. Thiercelin, S. Vožeh, LN Sansom, & Sidney Riegelman. (1977). The influence of cigarette smoking and sex on theophylline disposition.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 116(1). 17–23. 97 indexed citations
11.
Manson, J. I., et al.. (1975). BIOAVAILABILITY OF PHENYTOIN FROM VARIOUS PHARMACEUTICAL PREPARATIONS IN CHILDREN. The Medical Journal of Australia. 2(15). 590–592. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026